Skip to content

Immunomodulation in GWI (Phlebotomy)

Immunomodulation in GWI (Phlebotomy)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04058275
Enrollment
80
Registered
2019-08-15
Start date
2018-09-01
Completion date
2021-08-31
Last updated
2019-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gulf War Illness

Brief summary

Gulf War Illness and deployed veterans of the 1990-1991 Persian Gulf War are invited to have a brief history and physical examination to determine their health status, complete questionnaires, then donate about 83 ml of blood. There is no follow-up

Detailed description

Gulf War Illness and deployed veterans of the 1990-1991 Persian Gulf War are invited to have a brief history and physical examination to determine their health status, complete questionnaires, then donate about 83 ml of blood. There is no follow-up.

Interventions

OTHERDraw blood (phlebotomy, 83 ml)

Draw 83 ml of blood

Sponsors

Nova Southeastern University
CollaboratorOTHER
Georgetown University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Kansas Criteria for GWI * CDC criteria for CMI

Exclusion criteria

* Chronic medical or psychiatric disorder that may be responsible for symptoms of GWI

Design outcomes

Primary

MeasureTime frameDescription
Gene expression in peripheral blood mononuclear cellsAfter study recruitment, phleobotomy and mRNA quantification for all participants has been completed in June 2020Determine mRNA expression in peripheral blood mononuclear cells (PBMCs)

Countries

United States

Contacts

Primary ContactJames N Baraniuk, MD
baraniuj@georgetown.edu12026878231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026